Pacira BioSciences, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Pacira BioSciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q2 2024.
  • Pacira BioSciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $12.5M, a 14.3% increase year-over-year.
  • Pacira BioSciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $50.6M, a 4.81% increase year-over-year.
  • Pacira BioSciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $47.9M, a 0.41% decline from 2022.
  • Pacira BioSciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $48.1M, a 13.8% increase from 2021.
  • Pacira BioSciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $42.2M, a 5.83% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $50.6M $12.5M +$1.57M +14.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-30
Q1 2024 $49.1M $13.2M +$1.16M +9.68% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $47.9M $12.4M -$257K -2.03% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $48.2M $12.5M -$152K -1.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $48.3M $11M -$589K -5.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-30
Q1 2023 $48.9M $12M +$801K +7.16% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $48.1M $12.7M +$1.79M +16.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $46.3M $12.7M +$1.9M +17.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $44.4M $11.5M +$1.08M +10.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $43.3M $11.2M +$1.08M +10.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $42.2M $10.9M -$6K -0.06% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $42.3M $10.8M -$170K -1.55% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $42.4M $10.5M +$1.24M +13.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $41.2M $10.1M +$1.26M +14.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $39.9M $10.9M +$1.71M +18.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $38.2M $11M +$1.71M +18.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $36.5M $9.22M +$1.44M +18.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $35.1M $8.85M +$1.41M +19% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $33.7M $9.19M +$1M +12.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $32.6M $9.24M +$1.14M +14% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 $31.5M $7.78M +$736K +10.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $30.8M $7.43M -$951K -11.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $31.7M $8.19M -$8K -0.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $31.7M $8.11M -$555K -6.41% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $32.3M $7.05M -$298K -4.06% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $32.6M $8.39M +$985K +13.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $31.6M $8.19M +$461K +5.96% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $31.1M $8.66M +$1.3M +17.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $29.8M $7.35M -$320K -4.18% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $30.2M $7.4M -$1.09M -12.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 $31.2M $7.73M -$2M -20.5% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $33.2M $7.36M -$1.47M -16.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $34.7M $7.67M +$369K +5.06% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $34.3M $8.49M +$973K +12.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $33.4M $9.73M -$15.1M -60.8% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-28
Q3 2015 $48.5M $8.83M +$1.14M +14.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $47.3M $7.3M +$1.76M +31.8% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $45.6M $7.52M +$3.54M +89.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 $42M $24.8M +$21.5M +655% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $20.5M $7.69M +$3.91M +103% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-27
Q2 2014 $16.6M $5.54M +$3.31M +149% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-30
Q1 2014 $13.3M $3.98M +$1.75M +78.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-30
Q4 2013 $11.5M $3.29M +$1.73M +111% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-25
Q3 2013 $9.78M $3.78M +$2.31M +157% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-30
Q2 2013 $7.47M $2.23M +$1.19M +114% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 $6.29M $2.23M +$1.51M +213% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-01
Q4 2012 $4.78M $1.56M Oct 1, 2012 Dec 31, 2012 10-K 2015-02-24
Q3 2012 $1.47M +$1.03M +232% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-31
Q2 2012 $1.04M +$489K +88.7% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $712K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q3 2011 $442K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 $551K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.